Sun, Nov 23, 2014, 4:36 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • bbondslf25 bbondslf25 Jul 24, 2013 8:04 PM Flag

    Only Stubborn longs are holding this stock right now...

    This is not meant as a bash post, but its generally true... this reminds me of Blackberry after earnings... there is absolutely no news that could come out from SRPT that can drive this stock higher in the next few months... so ur essentially either holding a stock that is dead money for a while... or... ur holding a stock that will go down even more ( which is more likely). Again, I am not questioning the drug... it will eventually get approval, BUT, for the short term.... this is a bad stock to be invested in....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • system_architect_enterprise system_architect_enterprise Jul 24, 2013 10:25 PM Flag

      You may be right. I may be stubborn. I just think the stock is worth more than the share price it is trading at right now so I'm not selling. I'm not saying it won't go lower. In fact, I kinda hope it does because I'd like to add to my position. I got in at $25 so I'm not all that worried about it and I'm not in a rush to sell by any means.

      Sure I wish I got out yesterday afternoon and bought back today at the low (or maybe tomorrow or the next day if it goes lower) but I'm not much of a trader. So I'll watch the fireworks and see what happens. I do know a few things though. I know that I think the stock is worth more than it is trading at right now, and therefore I won't sell the shares I have. I also know that I'd like more shares so I need to start adding to my position, so the dip is OK by me.

    • Long time, no see.

 
SRPT
15.73-0.05(-0.32%)Nov 21 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.